The researchers included 261 patients across three randomized, controlled trials in their analysis.
Here’s what you need to know:
1. Intravenous ketamine was not inferior to intravenous morphine in terms of pain scale reduction in a patient-level data analysis.
2. The researchers said ketamine has a lesser risk of severe adverse reaction than morphine, but a greater risk of emergence phenomenon and dizziness.
3. There are adverse side effects for both drugs, the researchers said. Opioids are linked with vomiting, itching, nausea, low blood pressure, respiratory depression and hypoxia, along with the danger of misuse and addiction. Ketamine is also potentially addictive and is associated with symptoms in the lower urinary tract.
More articles on quality:
Ineffective tech slowing patient safety progress, healthcare execs say in Health Catalyst survey
Infection control association unveils resource for infection preventionists — 4 quick facts
ECRI Institute to continue guideline database shut down by HHS, launch site with new features this fall
